Selva R La, Violetti S Alberti, Delfino C, Grandi V, Cicchelli S, Tomasini C, Fierro M T, Berti E, Pimpinelli N, Quaglino P
Department of Medical Sciences, Dermatologic Clinic, University of Turin, Turin, Italy.
UOC Dermatologia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Indian J Dermatol. 2017 Mar-Apr;62(2):146-157. doi: 10.4103/ijd.IJD_74_17.
The term "Primary Cutaneous B-Cell Lymphoma" (PCBCL) comprehends a variety of lymphoproliferative disorders characterized by a clonal proliferation of B-cells primarily involving the skin. The absence of evident extra-cutaneous disease must be confirmed after six-month follow-up in order to exclude a nodal non-Hodgkin's lymphoma (NHL) with secondary cutaneous involvement, which may have a completely different clinical behavior and prognosis. In this article, we have summarized the clinico-pathological features of main types of PCBCL and we outline the guidelines for management based on a review of the available literature.
“原发性皮肤B细胞淋巴瘤”(PCBCL)这一术语涵盖了多种以B细胞克隆性增殖为主、主要累及皮肤的淋巴增殖性疾病。必须在六个月的随访后确认无明显的皮肤外疾病,以排除伴有继发性皮肤受累的淋巴结非霍奇金淋巴瘤(NHL),后者可能具有完全不同的临床行为和预后。在本文中,我们总结了PCBCL主要类型的临床病理特征,并根据现有文献综述概述了管理指南。